Publikationen 2024

Zetterman T, Nieminen AI, Markkula R, Kalso E, and Lötsch J. Machine learning identifies fatigue as a key symptom of fibromyalgia reflected in tyrosine, purine, pyrimidine, and glutaminergic metabolism. Clin Transl Sci 2024 Mar;17(3):e13740. doi: 10.1111/cts.13740.
Lötsch J, Wolter A, Hähner A, and Hummel T. Odor dilution sorting as a clinical test of olfactory function: normative values and reliability data. Chem Senses 2024 Feb 24:bjae008. doi: 10.1093/chemse/bjae008
Lötsch J, Brosig O, Slobodova J, Kringel D, Hähner A, and Hummel T. Odor dilution sorting as a clinical test of olfactory function: normative values and reliability data. Chem Senses 2024 Jan 1;49:bjad051. doi: 10.1093/chemse/bjad051
Mayer B, Kringel D, and Lötsch J. Artificial intelligence and machine learning in clinical pharmacological research. Expert Rev Clin Pharmacol 2024 Jan;17(1):79-91. doi: 10.1080/17512433.2023.2294005. Epub 2024 Jan 23
Rischke S, Gurke R, Bennett A, Behrens F, Geisslinger G, and Hahnefeld L. ALISTER - Application for lipid stability evaluation and research. Clin Chim Acta 2024 Mar 15;557:117858. doi: 10.1016/j.cca.2024.117858. Online ahead of print
Schicht M, Farger J, Wedel S, Sisignano M, Scholich K, Geisslinger G, Perumal N, Grus FH, Singh S, Sahin A, Paulsen F, and Lütjen-Drecoll E. Ocular surface changes in mice with streptozotocin-induced diabetes and diabetic polyneuropathy. Ocul Surf. 2024 Jan;31:43-55. doi: 10.1016/j.jtos.2023.12.006. Epub 2023 Dec 21
Kugler S, Hahnefeld L, Kloka JA, Ginzel S, Nürenberg-Goloub E, Zinn S, Vehreschild MJ, Zacharowski K, Lindau S, Ullrich E, Burmeister J, Kohlhammer J, Schwäble J, Gurke R, Dorochow E, Bennett A, Dauth S, Campe J, Knape T, Laux V, Kannt A, Köhm M, Geisslinger G, Resch E, Behrens F. Short-term predictor for COVID-19 severity from a longitudinal multi-omics study for practical application in intensive care units. Talanta 2024 Feb 1;268(Pt 1):125295. doi: 10.1016/j.talanta.2023.125295. Epub 2023 Oct 9
Schäufele TJ, Kolbinger A, Friedel J, Gurke R, Geisslinger G, Weigert A, Pierre S, and Scholich K. Meloxicam treatment disrupts the regional structure of innate inflammation sites by targeting the pro-inflammatory effects of prostanoids. Br J Pharmacol 2024 Apr;181(7):1051-1067. doi: 10.1111/bph.16261. Epub 2023 Nov 22
El Hindi K, Brachtendorf S, Hartel JC, Renné C, Birod K, Schilling K, Labocha S, Thomas D, Ferreirós N, Hahnefeld L, Dorochow E, Del Turco D, Deller T, Scholich K, Fuhrmann DC, Weigert A, Brüne B, Geisslinger G, Wittig I, Link KH, and Grösch S. Hypoxia induced deregulation of sphingolipids in colon cancer is a prognostic marker for patient outcome. Biochim Biophys Acta Mol Basis Dis. 2024 Jan;1870(1):166906. doi: 10.1016/j.bbadis.2023.166906
Hernandez-Olmos V, Heering J, Marinescu B, Schermeng T, Ivanov V, Moroz Y, Nevermann, S, Mathes M, Ehrler J, Alnouri WM, Wolf M, Haydo A, Schmachtel T, Zaliani A, Höfner G, Kaiser, A, Schubert-Zsilavecz, M, Beck-Sickinger A, Offermanns S, Gribbon, P, Rieger M, Merk, D, Sisignano M, Steinhilber, D, and Proschak E (2024). Development of a potent and selective G2A (GPR132) agonist. J Med Chem 2024 (accepted)